<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03281447</url>
  </required_header>
  <id_info>
    <org_study_id>020-2016-NQ</org_study_id>
    <secondary_id>2008-58-0035</secondary_id>
    <nct_id>NCT03281447</nct_id>
  </id_info>
  <brief_title>Nurse Navigation Versus Current Care Coordination During Colorectal Cancer Trajectories</brief_title>
  <acronym>NaviCan</acronym>
  <official_title>NaviCan. Navigation and Support to Cancer Patients - A Randomized Controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Odense University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Southern Denmark</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Laval University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Slagelse Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Region of Southern Denmark</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Region Zealand</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Danish Cancer Society</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Odense Patient Data Explorative Network</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Odense University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In western countries, the number of cancer survivors increases, and current cancer care seems&#xD;
      insufficient with both patients' experiences of lack of help in transitions and up to 60 % of&#xD;
      the patients having psychological problems after treatment. Further, Denmark shall have new&#xD;
      hospitals, where researchers and healthcare professionals are expected to merge tasks and&#xD;
      reach a higher patient experienced quality of care, without additional costs, so a better way&#xD;
      to provide cancer care, which benefits the patients and supports the ideas within the new&#xD;
      hospitals in Denmark, is needed.&#xD;
&#xD;
      In a randomized controlled trial, the organizational structure of the healthcare system is&#xD;
      challenged and the impact of a coherent nurse navigation practice compared to the currently&#xD;
      existing department-specific care coordination is tested. The primary data are changes in&#xD;
      patients' self-reported cancer-related self-efficacy from inclusion till one week after&#xD;
      receipt of the information that they have reached the end of treatment, or in case of&#xD;
      prolonged treatment, till not later than one year after inclusion.&#xD;
&#xD;
      Patients can participate if they are 18 years of age or older, speak and understand Danish,&#xD;
      and have a proven lesion suspected of cancer in the colon or rectum after colonoscopy or&#xD;
      sigmoidoscopy at the Danish endoscopy centers at Odense University Hospital (the cities:&#xD;
      Nyborg, Svendborg and Odense) or at Slagelse Hospital. Furthermore, participants must not be&#xD;
      mentally retarded, they must not suffer from a constant life-threatening disease, and they&#xD;
      must not suffer from, or be in the diagnostic phase of, dementia or severe psychiatric&#xD;
      disease.&#xD;
&#xD;
      Participants are allocated to support from nurse navigation or to current care coordination,&#xD;
      and fill in four questionnaires during their cancer trajectory: 1) At inclusion, 2) Three&#xD;
      days before treatment start, 3) One week after receipt of information about treatment end or&#xD;
      not later than one year after inclusion, and 4) Six weeks after measure point 3. Data is&#xD;
      analyzed using suitable statistical models.&#xD;
&#xD;
      With positive results, participants in nurse navigation are better helped during their cancer&#xD;
      trajectory and have a better psychological start on the rest of their lives after cancer&#xD;
      treatment. Focus will be on colon and rectum cancer care, but the results will be&#xD;
      transferable to similar settings. Furthermore, positive results will support changes in the&#xD;
      onset of rehabilitation initiatives.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary hypothesis in this study is:&#xD;
&#xD;
      Nurse navigation, as a specific, defined concept of coherent help through cancer&#xD;
      trajectories, will prove superior to current care coordination with regard to patients'&#xD;
      self-evaluated self-efficacy for cancer from inclusion to one week after receipt of&#xD;
      information about treatment end or not later than one year after inclusion.&#xD;
&#xD;
      Allocation The randomization will be stratified by age and gender. The rational is that age&#xD;
      and gender is differently associated with benefit by a given care.&#xD;
&#xD;
      Data collection Participants fill in questionnaires at four measurements, and supplements to&#xD;
      sociodemographic information as well as information for an economic evaluation is collected&#xD;
      from provider side.&#xD;
&#xD;
      The questionnaires for participants are available in paper and electronically, and&#xD;
      participants are allowed to discuss the individual questions with a person whom they trust&#xD;
      before filling in their answers. If a participant is blind or dyslexic and has no one to help&#xD;
      them fill in the questionnaires, a trained study nurse will read out loud the questions and&#xD;
      fill in the participant's answers, and eventually in this process, listen to the&#xD;
      participant's pros and cons, acknowledge that they are heard, ask for an answer and read out&#xD;
      loud the question again. All data are stored in Research Electronic Data Capture (RedCap).&#xD;
&#xD;
      Blinding The trial is not blinded but all participants are told, there is no favorite group.&#xD;
      The statistician is blinded to randomization group and this blinding will be unveiled after&#xD;
      the data is analyzed.&#xD;
&#xD;
      Statistics Data are analyzed following the modified intention-to-treat principle, which is&#xD;
      carried out by a senior statistician in close collaboration with the research group. Usual&#xD;
      descriptive statistics will be used to summarize baseline and subject characteristics. The&#xD;
      analyses of the primary endpoint, i.e. change in self-evaluated self-efficacy for cancer from&#xD;
      inclusion (measurement 1) to end of treatment (measurement 3), and the secondary outcomes are&#xD;
      done using analysis of covariance of the measure at measurement 3 with randomization group as&#xD;
      a factor and measure at measurement 1 as covariate. In secondary analyses for all endpoints&#xD;
      (measurement 1-4), the change over time will be investigated by mixed effects repeated&#xD;
      measures analysis with randomization group as factor and random effects for subjects. These&#xD;
      analyses are repeated within the subgroup of all cancer patients and the subgroup of cancer&#xD;
      patients treated with curative aim. In the subgroup analyses, the influence of relevant&#xD;
      subject-level confounders such as age, disease-stage, treatment, etc. will be explored, and&#xD;
      appropriate adjustment will be performed. An economic evaluation will be performed for each&#xD;
      randomized group and compared.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 26, 2016</start_date>
  <completion_date type="Actual">December 31, 2018</completion_date>
  <primary_completion_date type="Actual">October 23, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Self evaluated Self Efficacy for Cancer</measure>
    <time_frame>Change in &quot;Cancer Behaviour Inventory - Brief&quot; from inclusion to measurement 3: one week after receipt of information about treatment end or not later than one year after inclusion.</time_frame>
    <description>Cancer Behaviour Inventory - Brief</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Self evaluated Self Efficacy for Cancer</measure>
    <time_frame>Change in &quot;Cancer Behaviour Inventory - Brief&quot; from inclusion to three days before treatment start.</time_frame>
    <description>Cancer Behaviour Inventory - Brief</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self evaluated Self Efficacy for Cancer</measure>
    <time_frame>Change in &quot;Cancer Behaviour Inventory - Brief&quot; from inclusion to six weeks after measurement 3.</time_frame>
    <description>Cancer Behaviour Inventory - Brief</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self evaluated Self Efficacy for Cancer</measure>
    <time_frame>Change in &quot;Cancer Behaviour Inventory - Brief&quot; from three days before treatment start to measurement 3: one week after receipt of information about treatment end or not later than one year after inclusion.</time_frame>
    <description>Cancer Behaviour Inventory - Brief</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self evaluated Self Efficacy for Cancer</measure>
    <time_frame>Change in &quot;Cancer Behaviour Inventory - Brief&quot; from three days before treatment start to six weeks after measurement 3.</time_frame>
    <description>Cancer Behaviour Inventory - Brief</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self evaluated Self Efficacy for Cancer</measure>
    <time_frame>Change in &quot;Cancer Behaviour Inventory - Brief&quot; from one week after measurement 3: one week after receipt of information about treatment end or not later than one year after inclusion to six weeks after measure point 3.</time_frame>
    <description>Cancer Behaviour Inventory - Brief</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Continuity of care</measure>
    <time_frame>Change in &quot;Continuity of care&quot; from inclusion to measurement 3: one week after receipt of information about treatment end or not later than one year after inclusion.</time_frame>
    <description>Qualitatively validated questions answered by participants</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Continuity of care</measure>
    <time_frame>Change in &quot;Continuity of care&quot; from inclusion to three days before treatment start.</time_frame>
    <description>Qualitatively validated questions answered by participants</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Continuity of care</measure>
    <time_frame>Change in &quot;Continuity of care&quot; from inclusion to six weeks after measurement 3.</time_frame>
    <description>Qualitatively validated questions answered by participants</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Continuity of care</measure>
    <time_frame>Change in &quot;Continuity of care&quot; from three days before treatment start to measurement 3: one week after receipt of information about treatment end or not later than one year after inclusion.</time_frame>
    <description>Qualitatively validated questions answered by participants</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Continuity of care</measure>
    <time_frame>Change in &quot;Continuity of care&quot; from three days before treatment start to six weeks after measurement 3.</time_frame>
    <description>Qualitatively validated questions answered by participants</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Continuity of care</measure>
    <time_frame>Change in &quot;Continuity of care&quot; from one week after measurement 3: one week after receipt of information about treatment end or not later than one year after inclusion to six weeks after measure point 3.</time_frame>
    <description>Qualitatively validated questions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Unmet needs</measure>
    <time_frame>Change in &quot;Unmet needs&quot; from three days before treatment start to measurement 3: one week after receipt of information about treatment end or not later than one year after inclusion.</time_frame>
    <description>Patients experienced needs and degree of fulfilled support</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Unmet needs</measure>
    <time_frame>Change in &quot;Unmet needs&quot; from three days before treatment start to six weeks after measurement 3.</time_frame>
    <description>Patients experienced needs and degree of fulfilled support</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Unmet needs</measure>
    <time_frame>Change in &quot;Cancer Behaviour Inventory - Brief&quot; from one week after measurement 3: one week after receipt of information about treatment end or not later than one year after inclusion to six weeks after measure point 3.</time_frame>
    <description>Patients experienced needs and degree of fulfilled support</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health-related Quality of Life</measure>
    <time_frame>Change in &quot;Health-related Quality of Life&quot; from three days before treatment start to six weeks after measurement 3.</time_frame>
    <description>European Organisation for Research and Treatment of Cancer Quality of life questionnaire with 30 questions (EORCT QLQ-c30).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">280</enrollment>
  <condition>Self Efficacy</condition>
  <condition>Continuity of Care</condition>
  <condition>Quality of Life</condition>
  <condition>Colorectal Neoplasms</condition>
  <condition>Case Management</condition>
  <arm_group>
    <arm_group_label>Nurse navigation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Coherent navigation and support from a family-centred viewpoint throughout the cancer trajectory, despite the individual patient's affiliation to any department.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Current care coordination</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Department-specific coordination and answers to questions from a patient-centred viewpoint.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Nurse navigation</intervention_name>
    <arm_group_label>Nurse navigation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Current care coordination</intervention_name>
    <arm_group_label>Current care coordination</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Lesions suspected for cancer in the colon or rectum recognized through colonoscopy or&#xD;
             sigmoidoscopy found at scopy centres in Odense, Nyborg, Svendborg or Slagelse, all in&#xD;
             Denmark&#xD;
&#xD;
          -  Can speak and understand Danish.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Life-threatening disease: score 4 in the American Society of Anaesthesiologists status&#xD;
             classification system.&#xD;
&#xD;
          -  Dementia ( Diagnosed or in a diagnostic phase).&#xD;
&#xD;
          -  Severe psychiatric disease ( Diagnosed or in a diagnostic phase).&#xD;
&#xD;
          -  Mentally retarded ( Diagnosed or in a diagnostic phase).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lise Fillion, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Nursing Faculty, Laval University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jens SÃ¸ndergaard, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Research Unit of General Practice, Faculty of Health Sciences, University of Southern Denmark</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marianne K Thygesen, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Surgery department A, Clinical Institute, Faculty of Health Sciences, University of Southern Denmark and OPEN at Region of Southern Denmark</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Niels Qvist, DMSc</last_name>
    <role>Study Director</role>
    <affiliation>Surgery department A, Clinical Institute, Faculty of Health Sciences, University of Southern Denmark</affiliation>
  </overall_official>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>September 11, 2017</study_first_submitted>
  <study_first_submitted_qc>September 12, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">September 13, 2017</study_first_posted>
  <last_update_submitted>April 2, 2019</last_update_submitted>
  <last_update_submitted_qc>April 2, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 4, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Odense University Hospital</investigator_affiliation>
    <investigator_full_name>Marianne K. Thygesen</investigator_full_name>
    <investigator_title>Associate professor</investigator_title>
  </responsible_party>
  <keyword>Nurse navigation</keyword>
  <keyword>Family</keyword>
  <keyword>Self Efficacy</keyword>
  <keyword>Needs assessment</keyword>
  <keyword>Quality of Life</keyword>
  <keyword>Colorectal Neoplasms</keyword>
  <keyword>Case Management</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

